Sanjana Singh is a Research Assistant with PORTAL. Her research interests include direct-to-consumer advertising, FDA interactions with industry and the public, and GLP-1 medications. Singh received her bachelor’s degree in the History of Science from Harvard College and plans to pursue a medical degree.
Her senior thesis examined Dexatrim, an over-the-counter weight-loss medication widely marketed and used in the 1980s and 1990s. Using Dexatrim as a case study, her research explored FDA regulatory decision-making, industry-funded research, pharmaceutical marketing, and the shifting definitions of acceptable risk that shaped the drug’s commercial success. She has also contributed to research on Alzheimer’s Disease and antimicrobial resistance prevention.